Welcome to our dedicated page for EXELA TECHS 6% SER B news (Ticker: XELAP), a resource for investors and traders seeking the latest updates and insights on EXELA TECHS 6% SER B stock.
Exela Technologies Inc is a business process automation (BPA) leader combining industry-specific and multi-industry enterprise software and solutions. The company's BPA suite of solutions is deployed in banking, healthcare, insurance, and other industries. The company's segment includes Information and Transaction Processing Solutions (ITPS), Healthcare Solutions (HS), and Legal and Loss Prevention Services (LLPS). It generates maximum revenue from the ITPS segment.
Exela Technologies reminds its stockholders to vote ahead of the upcoming annual meeting on June 13, 2024, at 10:00 AM CT. The meeting, which will be held online, seeks approval for several key proposals. These include the election of directors, executive compensation, the adoption of a 2024 stock incentive plan, and amendments to the Series B Certificate of Designations. Stockholders are encouraged to vote by proxy. Detailed instructions and relevant documents are available on the SEC and Exela’s investor relations websites.
Exela Technologies (NASDAQ:XELA, XELAP) will host a conference call on May 28, 2024, at 4:30 p.m. ET to discuss its first-quarter 2024 financial results. The call will feature Par Chadha, Executive Chairman, and Matt Brown, Interim CFO. The webcast will be accessible via Exela's Investor Relations website, with a replay available until June 4, 2024. Interested parties can find more updates on Exela's financial news by subscribing to email alerts on their Investor Relations site.
Exela Technologies (NASDAQ: XELA) reported its Q1 2024 financial results, highlighting a revenue decline of 5.4% year-over-year to $258.8 million. The gross margin improved by 1.1% to 22.0%. The company reported a significant reduction in interest expense by 52.3% to $21.1 million.
Operating profit was up, reaching $0.1 million compared to a loss of $6.9 million in the previous year. However, the net loss stood at $25.6 million, which showed an improvement of $19.9 million year-over-year. Adjusted EBITDA dropped by 11.1% to $12.9 million but showed a sequential increase of 41.7%.
Segment-wise, Information and Transaction Processing Solutions generated $176.1 million, down 9.1% year-over-year. Healthcare Solutions saw a revenue increase of 2.9% to $64.9 million, and Legal and Loss Prevention Services revenue rose by 5.6% to $17.8 million.
FAQ
What is the current stock price of EXELA TECHS 6% SER B (XELAP)?
What does Exela Technologies Inc specialize in?
In which industries does Exela Technologies Inc operate?
What are the primary revenue-generating segments for Exela Technologies Inc?
How many customers does Exela Technologies Inc serve?